Tha answers to today’s problems ...

168 people finished in under a minute. We created a crossword puzzle just for Californians. 248 people are playing right now. Catch the 49ers take on the Seahawks on Saturday, January 17. Here’s ...

After starting as a production assistant, "Trapper" Dave Calabrese filled in for other DJs at WPLR and had his own show on Saturdays. "I’ll meet you in the music. Come find me anytime," said ...

At first glance, the image looks like black and grey television static. The image is filled with tiny specks of light and dark so densely that your eyes may not know where to focus. But mind you, this ...

State pensioners have been reminded a two-digit code determines when they receive their payments. Department for Work and Pensions, or DWP, state pension payments could arrive at different points in ...

We may receive a commission on purchases made from links. Oscillating multi-tools can be an invaluable part of your toolkit, not least because they can be used for so many different applications.

A single ticket sold in New Jersey won the $90 million Mega Millions jackpot on Tuesday, Dec. 2, 2025. The winning numbers for the drawing were 17, 25, 26, 53, 60, and the Mega Ball was 16. Following ...

Player can pick six numbers from two separate pools of numbers — five different numbers from 1 to 70 (the white balls) and one number from 1 to 24 (the gold Mega Mall). Players can also select the ...

A ticket sold in Georgia won the $980 million Mega Millions jackpot on Nov. 14. The jackpot for the Tuesday, Dec. 2, drawing is an estimated $90 million. The next Mega Millions drawing will take place ...

Washington's defense was so bad that head coach Dan Quinn finally took over defensive play-calling from defensive coordinator Joe Whitt Jr. ahead of Week 11. While Whitt had his issues, he was far ...

Property and casualty insurance and reinsurance companies consistently trade at low valuations despite strong fundamentals. These companies are uncorrelated to the market as a whole. The sector's ...

Roche said its fenebrutinib drug candidate met primary goals in two late-stage trials for multiple sclerosis, reducing attacks or delaying disability progression in two different forms of the disease.